Tag: Revive Therapeutics

0 603

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences…

 Leave a comment    Posted in Psychedelics Tagged ,